VivoPower PLC (VIVO)

NASDAQ: VIVO · Real-Time Price · USD
1.890
-0.180 (-8.70%)
At close: Mar 16, 2026, 4:00 PM EDT
1.890
0.00 (0.00%)
After-hours: Mar 16, 2026, 4:10 PM EDT
Market Cap31.73M -96.5%
Revenue (ttm)61,000 +281.3%
Net Income-12.79M
EPS-1.92
Shares Out 16.79M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume521,943
Open1.860
Previous Close2.070
Day's Range1.690 - 1.945
52-Week Range0.619 - 8.880
Beta-1.66
Analystsn/a
Price Targetn/a
Earnings DateNov 22, 2022

About VIVO

VivoPower PLC, together with its subsidiaries, provides energy solutions for customized and ruggedized fleet applications, battery and microgrids, and solar and critical power technology and services. It operates through Electric Vehicles, Sustainable Energy Solutions, Solar Development, and Digital Assets segments. The Electric Vehicles segment offers ruggedized battery-powered Electric Vehicle (EV) solutions, including conversion kits for fleet owners in the mining, agriculture, energy utility, defense, police, government, public transport, h... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2014
Employees 41
Stock Exchange NASDAQ
Ticker Symbol VIVO
Full Company Profile

Financial Performance

In fiscal year 2025, VivoPower's revenue was $61,000, an increase of 281.25% compared to the previous year's $16,000. Losses were -$12.79 million, -72.61% less than in 2024.

Financial Statements

News

VivoPower Announces Effectiveness of New Stock Ticker “VIVO” and Corporate Name Change

LONDON, March 16, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data cen...

Other symbols: VVPR
9 hours ago - GlobeNewsWire

Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced that a broad portfolio of its Alethia ...

20 days ago - Business Wire

SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience

CINCINNATI and SEOUL, South Korea , Jan. 31, 2023 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, an...

3 years ago - PRNewsWire

Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger

CINCINNATI , Dec. 12, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has ent...

3 years ago - PRNewsWire

MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS

CINCINNATI , Nov. 22, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2022. Fourth Quarter 20...

3 years ago - PRNewsWire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TMX, VIVO, RFP, SBTX

NEW YORK , Sept. 26, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breache...

Other symbols: RFP
3 years ago - PRNewsWire

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, VIVO, EGY, STCN

NEW YORK , Aug. 22, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches...

Other symbols: EGYRFPSTCN
3 years ago - PRNewsWire

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, VIVO, HNGR, CMAX

NEW YORK , Aug. 15, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches...

Other symbols: BHVN
3 years ago - PRNewsWire

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, ONEM, HNGR

NEW YORK , Aug. 8, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...

3 years ago - PRNewsWire

MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

CINCINNATI , Aug. 5, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter ended June 30, 2022. Third Quarter Fiscal 2022 Highlights (Co...

3 years ago - PRNewsWire

Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay

CINCINNATI , July 29, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it receive...

3 years ago - PRNewsWire

MERIDIAN BIOSCIENCE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO

NEW ORLEANS , July 27, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

3 years ago - PRNewsWire

MERIDIAN BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Meridian Bioscie...

4 years ago - Business Wire

Meridian Bioscience agrees to $1.5 billion buyout by SD Biosensor, SJL Partners

Meridian Bioscience Inc. VIVO, +7.02% announced an agreement Thursday to be acquired by a consortium of South Korea-based SD Biosensor Inc. 137310, +2.08% and private equity firm SJL Partners LLC in a...

4 years ago - Market Watch

Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction

Shareholders to Receive $34.00 Per Share in Cash, Providing Immediate, Compelling and Certain Value Transaction Follows Deliberate Review, Including Outreach to Potential Strategic and Financial Partn...

4 years ago - PRNewsWire

Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter

CINCINNATI , July 7, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materia...

4 years ago - PRNewsWire

Meridian Bioscience Is Not Your Average Life Science Company

100% technical buy signals. 8 new highs and up 15.79% in the last month.

4 years ago - Seeking Alpha

Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular Assays

CINCINNATI , June 20, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today two new s...

4 years ago - PRNewsWire

Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests

CINCINNATI , May 26, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that its i...

4 years ago - PRNewsWire

Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment Conference

CINCINNATI , May 23, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today its partic...

4 years ago - PRNewsWire

Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays

CINCINNATI , May 17, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the contin...

4 years ago - PRNewsWire

Meridian Bioscience's Q2 Revenues Increase 30% To $111M, Highest In Company History

Meridian Bioscience Inc (NASDAQ: VIVO) reported a 30% increase in Q2 sales to $111.2 million, the highest in the company's history, with both segments ahead of expectations, beating the consensus of $...

4 years ago - Benzinga

Meridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q2 2022 Results - Earnings Call Transcript

Meridian Bioscience, Inc. (NASDAQ:VIVO) Q2 2022 Earnings Conference Call May 6, 2022 10:00 AM ET Corporate Participants Charlie Wood - Vice President of Investor Relations Jack Kenny - Chief Executiv...

4 years ago - Seeking Alpha

MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS

CINCINNATI , May 6, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2022. Second Quarter Fiscal 2022 Highlights (...

4 years ago - PRNewsWire

Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities

CINCINNATI, Ohio, May 2, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that i...

4 years ago - PRNewsWire